Cornuside suppresses lipopolysaccharide-induced inflammatory mediators by inhibiting nuclear factor-kappa B activation in RAW 264.7 macrophages

Biological and Pharmaceutical Bulletin

Volumn 34, Issue 7, 2011, Pages 959-966

  Choi, Yun Ho ^a   Jin, Guang Yu ^b   Li, Guang Zhao ^b   Yan, Guang Hai ^b  

^a Chonbuk National University   (South Korea)

^b YANBIAN UNIVERSITY   (China)

Author keywords

Cornuside; Cyclooxygenase 2; Inducible nitric oxide synthase; Lipopolysaccharide; Nuclear factor kappa B

Indexed keywords

ANTIINFLAMMATORY AGENT; CORNUSIDE; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; PROSTAGLANDIN E2; STRESS ACTIVATED PROTEIN KINASE 1; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL NUCLEUS; CELL STIMULATION; CONTROLLED STUDY; CYTOTOXICITY TEST; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT;

ANIMALS; BASE SEQUENCE; CELL LINE; CYCLOOXYGENASE 2; CYTOKINES; DINOPROSTONE; DNA PRIMERS; GLUCOSIDES; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; PROTEIN KINASES; PYRANS; RNA, MESSENGER;

EID: 79960315345     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.34.959     Document Type: Article

References (38)

1. Lin W. W., Karin M., J. Clin. Invest., 117, 1175-1183 (2007).
2. Lawrence T., Willoughby D. A., Gilroy D. W., Nat. Rev. Immunol., 2, 787-795 (2002).
3. Xie Q. W., Kashiwabara Y., Nathan C., J. Biol. Chem., 269, 4705-4708 (1994).
4. Lawrence T., Cold Spring Harb. Perspect. Biol., 1, a001651 (2009).
5. Chatterjee A., Black S. M., Catravas J. D., Vascul. Pharmacol., 49, 134-140 (2008).
6. Chu Q., Satoh K., Kanamoto T., Terakubo S., Nakashima H., Wang Q., Sakagami H., Anticancer Res., 29, 3211-3219 (2009).
7. Sung Y. H., Chang H. K., Kim S. E., Kim Y. M., Seo J. H., Shin M. C., Shin M. S., Yi J. W., Shin D. H., Kim H., Kim C. J., J. Med. Food, 12, 788-795 (2009).
8. Chu Q., Hashimoto K., Satoh K., Wang Q., Sakagami H., In Vivo, 23, 537-544 (2009).
9. Chen C. C., Hsu C. Y., Chen C. Y., Liu H. K., J. Ethnopharmacol., 117, 483-490 (2008).
10. Kang D. G., Moon M. K., Lee A. S., Kwon T. O., Kim J. S., Lee H. S., Biol. Pharm. Bull., 30, 1796-1799 (2007).
11. Jiang W. L., Chen X. G., Zhu H. B., Hou J., Tian J. W., Pharmacology, 84, 162-170 (2009).
12. Jiang W. L., Chen X. G., Zhu H. B., Tian J. W., Planta Med., 75, 614-619 (2009).
13. Philippeaux M. M., Bargetzi J. P., Pache J. C., Robert J., Spiliopoulos A., Mauël J., Eur. J. Cell Biol., 88, 243-256 (2009).
14. Tsikas D., J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 851, 51-70 (2007).
15. Guha M., Mackman N., Cell. Signal., 13, 85-94 (2001).
16. Caivano M., Cohen P., J. Immunol., 164, 3018-3025 (2000).
17. Choi K. C., Lee Y. H., Jung M. G., Kwon S. H., Kim M. J., Jun W. J., Lee J., Lee J. M., Yoon H. G., Mol. Cancer Res., 7, 2011-2021 (2009).
18. Kwon S. H., Park H. Y., Kim J. Y., Jeong I. Y., Lee M. K., Seo K. I., Bioorg. Med. Chem. Lett., 20, 6435-6438 (2010).
19. Yamabe N., Noh J. S., Park C. H., Kang K. S., Shibahara N., Tanaka T., Yokozawa T., Eur. J. Pharmacol., 648, 179-187 (2010).
20. Cao G., Zhang Y., Cong X. D., Cai H., Cai B. C., Zhongguo Yao Xue, 18, 208-213 (2009).
21. Hatano T., Yasuhara T., Abe R., Okuda T., Phytochemistry, 29, 2975-2978 (1990).
22. Park K. S., Kim B. H., Chang I. M., Evid. Based Complement. Alternat. Med., 7, 41-45 (2010).
23. Duffield J. S., Clin. Sci. (London), 104, 27-38 (2003).
24. Sprague A. H., Khalil R. A., Biochem. Pharmacol., 78, 539-552 (2009).
25. Chakraborti A. K., Garg S. K., Kumar R., Motiwala H. F., Jadhavar P. S., Curr. Med. Chem., 17, 1563-1593 (2010).
26. Scher J. U., Pillinger M. H., J. Investig. Med., 57, 703-708 (2009).
27. Mazza J., Rossi A., Weinberg J. M., Dermatol. Clin., 28, 559-575 (2010).
28. Weber T. J., Smallwood H. S., Kathmann L. E., Markillie L. M., Squier T. C., Thrall B. D., Am. J. Physiol. Cell Physiol., 290, C1512-C1520 (2006).
29. Kim E. K., Choi E. J., Biochim. Biophys. Acta, 1802, 396-405 (2010).
30. Schulze-Osthoff K., Ferrari D., Riehemann K., Wesselborg S., Immunobiology, 198, 35-49 (1997).
31. Vanden Berghe W., Plaisance S., Boone E., De Bosscher K., Schmitz M. L., Fiers W., Haegeman G., J. Biol. Chem., 273, 3285-3290 (1998).
32. Chen C. C., Wang J. K., Mol. Pharmacol., 55, 481-488 (1999).
33. Kole L., Giri B., Manna S. K., Pal B., Ghosh S., Eur. J. Pharmacol., 653, 8-15 (2011).
34. Kim I. S., Park Y. J., Yoon S. J., Lee H. B., Int. Immunopharmacol., 10, 1616-1625 (2010).
35. Kim J. H., Park Y. M., Shin J. S., Park S. J., Choi J. H., Jung H. J., Park H. J., Lee K. T., Biol. Pharm. Bull., 32, 1062-1068 (2009).
36. Cho W., Nam J. W., Kang H. J., Windono T., Seo E. K., Lee K. T., Int. Immunopharmacol., 9, 1049-1057 (2009).
37. Oeckinghaus A., Ghosh S., Cold Spring Harb. Perspect. Biol., 1, a000034 (2009).
38. Surh Y. J., Chun K. S., Cha H. H., Han S. S., Keum Y. S., Park K. K., Lee S. S., Mutat. Res., 480-481, 243-268 (2001).